93
Views
2
CrossRef citations to date
0
Altmetric
Original Research

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

, , ORCID Icon, , , , , , & show all
Pages 2307-2315 | Published online: 03 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Thibaud Mathis & Laurent Kodjikian. (2022) Do new drugs for diabetic macular edema offer a safer option?. Expert Opinion on Drug Safety 21:12, pages 1453-1457.
Read now

Articles from other publishers (1)

Olapeju A. Sam-Oyerinde & Praveen J. Patel. (2023) Real-World Outcomes of Anti-VEGF Therapy in Diabetic Macular Oedema: Barriers to Treatment Success and Implications for Low/Lower-Middle-Income Countries. Ophthalmology and Therapy 12:2, pages 809-826.
Crossref